In a large study, diabetic subjects receiving IGF-I for 12 weeks experienced major decreases in insulin requirements (Morrow et al, 1994), but side effects included edema, jaw pain, tachycardia and worsening of retinopathy (Quattrin et al, 1997). This evidence concerns the gene INS and retinal disorder.